Implantable cardioverter defibrillators: From evidence of trials to clinical practice

European Heart Journal, Supplement

Volumn 9, Issue I, 2007, Pages

  Boriani, Giuseppe ^a   Ricci, Renato ^b   Toselli, Tiziano ^c,d   Ferrari, Roberto ^c,d   Branzi, Angelo ^a   Santini, Massimo ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c Azienda Ospedaliera Universitaria di Ferrara   (Italy)

^d IRCCS   (Italy)

Author keywords

Cardioverter defibrillator; Cost; Cost effectiveness; Health care system; Heart failure; Sudden cardiac death

Indexed keywords

EID: 58149104403     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum060     Document Type: Article

References (34)

1. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80(Suppl. 5B):10F-19F.
2. Josephson M, Wellens HJ. Implantable defibrillators and sudden cardiac death. Circulation 2004;109:2685-2691.
3. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163.
4. Boriani G, Valzania C, Diemberger I, Biffi M, Martignani C, Bertini M, Ziacchi M, Domenichini G, Saporito D, Rapezzi C, Branzi A. Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death. Expert Opin Investig Drugs 2007;16:605-623.
5. Boriani G, Biffi M, Martignani C, Camanini C, Grigioni F, Rapezzi C, Branzi A. Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs. Eur J Heart Failure 2003;5:419-425.
6. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di MC, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task Force on Sudden Cardiac Death, European Society of Cardiology. Europace 2002;4:3-18.
7. Al-Khatib SM, Sanders GD, Mark DB, Lee KL, Bardy GH, Bigger JT, Buxton AE, Connolly S, Kadish A, Moss A, Feldman AM, Ellenbogen KA, Singh S, Califf RM. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 2005;149:1020-1034.
8. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B;. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2006;8:746-837.
9. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352: 225-237.
10. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-373.
11. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes III NAM, Favale S, Piccininno M, Winters SL, Santini M, Batocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Prevention of sudden cardiac death and selection of patients for implantable cardioverter-defibrillators in hypertrophic cardiomyopathy. JAMA 2007;298:405-412.
12. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Garrard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jais P, Pasquiè JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haissaguerre M, Mansourati J, Clémenty J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006;114:2317-2324.
13. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2005;2:1188-1194.
14. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003;14:337-341.
15. Sweeney MO, Schoenfeld MH, Cannom DS. Rules of evidence: CMS and primary prevention of sudden cardiac death in systolic heart failure. Pacing Clin Electrophysiol 2005;28:81-88.
16. Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction. Arch Intern Med 2006;166:2228-2233.
17. Boriani G, Biffi M, Russo M, Lunati M, Botto G, Proclemer A, Vergara G, Rahue W, Martignani C, Ricci R, Santini M. Primary prevention of sudden cardiac death: can we afford the cost of cardioverter-defibrillators? Data from the Search-MI Registry-Italian Sub-study. Pacing Clin Electrophysiol 2006;29(Suppl. 2):S29-S34.
18. Meltzer MI. Introduction to health economics for physicians. Lancet 2001;358:993-998.
19. Boriani G, Biffi M, Martignani C, Gallina M, Branzi A. Costeffectiveness of implantable cardioverter-defibrillators. Eur Heart J 2001;22:990-996.
20. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-1480.
21. Lynd LD, O'Brien BJ. Cost-effectiveness of the implantable cardioverter-defibrillator: a review of current evidence. J Cardiovasc Electrophysiol 2003;14:S99-S103.
22. Hlatky MA, Bigger JT. Cost-effectiveness of the implantable cardioverter defibrillator. Lancet 2001;357:1817-1818.
23. Mark DB, Nelson CL, Anstrom KJ, Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006;114:135- 142.
24. Caro JJ, Ward A, Deniz HB, O'Brien JA, Ehreth JL. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator (ICD) vs Amiodarone. Value Health 2007;10: 13-22.
25. Boriani G. Cardioverter defibrillators in primary prevention of sudden cardiac death: a cost or an investment? Value Health 2007;10:1-2.
26. Camm AJ. Heart Failure and sudden death: future use of anti-arrhythmic drugs and devices. Eur Heart J Suppl 2003;5:I108-I115.
27. Moss AJ. Findings in MADIT II substudies. Eur Heart J Suppl 2003;5: I34-I38.
28. Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT II-eligible population. J Am Coll Cardiol 2006;48:112-121.
29. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-943.
30. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol 2006;97:1255-1261.
31. Boriani G, Biffi M, Dall'Acqua A, Martignani C, Frabetti L, Zannoli R, Branzi A. Rhythm discrimination by Rate-Branch and QRS morphology in dual chamber implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2003;26:466-470.
32. Aliot E, Nitzschè R, Ripart A. Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms. Europace 2004;6:273-286.
33. Wathen M. Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies. Am Heart J 2007; 153(Suppl. 4):44-52.
34. Boriani G, Maron B, Shen WK, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation 2004;110:e438-e442.